Mechanisms of development of multiple endocrine neoplasia type 2 and Hirschsprung's disease by ret mutations

Area of Science:

• Genetics
• Molecular Biology
• Oncology

Background:

• The ret proto-oncogene encodes a receptor tyrosine kinase involved in development.
• Germline mutations in ret are linked to multiple endocrine neoplasia (MEN) types 2A and 2B, and Hirschsprung's disease (HSCR).

Purpose of the Study:

• To elucidate the molecular mechanisms underlying Ret activation in MEN2A and MEN2B.
• To understand the loss-of-function mechanisms of Ret in HSCR.
• To investigate Ret mutations associated with both MEN2A and HSCR phenotypes.

Main Methods:

• Analysis of Ret proto-oncogene mutations.
• Investigating Ret protein expression and dimerization.
• Correlating specific mutations with clinical phenotypes (MEN2A, MEN2B, HSCR).

Main Results:

• MEN2A mutations activate Ret via dimerization through extracellular cysteine residues.
• MEN2B mutations activate Ret through conformational changes in the tyrosine kinase domain.
• HSCR mutations often impair Ret cell surface expression, leading to loss of function.
• Specific Ret mutations (Cys618, Cys620) can lead to both MEN2A and HSCR, suggesting dual biological effects.

Conclusions:

• Ret mutations have diverse functional consequences, from constitutive activation to loss of function.
• The location and type of ret mutation dictate the resulting clinical phenotype.
• Understanding these genotype-phenotype correlations is crucial for diagnosing and managing associated diseases.